Wikidata

(Q43780694)

English

Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer

scientific article published in June 2001

In more languages

Statements

title
Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11408493
retrieved
26 November 2017
author name string
M Baekelandt
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11408493
retrieved
26 November 2017
I Szántó
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11408493
retrieved
26 November 2017
P Pfeiffer
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11408493
retrieved
26 November 2017
B Gustavssson
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
11408493
retrieved
26 November 2017
G B Kristensen
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
11408493
retrieved
26 November 2017
publication date
1 June 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11408493
retrieved
26 November 2017
page(s)
2983-2993
1 reference
stated in
Europe PubMed Central
PubMed ID
11408493
retrieved
26 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43780694&oldid=2103270015"